Development of simple to use point of care tests for zoonotic pathogens and thei...
Development of simple to use point of care tests for zoonotic pathogens and their validation for use in clinical research setting
Our major goal is development of simple to use point of care tests for zoonotic pathogens and viral hemorrhagic fevers (VHF), and their validation for use in clinical research setting.
Zoonosis is any process whereby an infectiou...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
PRONTO
self-PoweRed cONductimeter for digiTalization of rapid mOlec...
150K€
Cerrado
PodiTrodi-EU
Technology Platform for Point of Care Diagnostics for Tropic...
2M€
Cerrado
PID2020-119195RJ-I00
PRODUCCION DE BIOSENSORES DE FLAVIVIRUS: NUEVAS HERRAMIENTAS...
182K€
Cerrado
RAPP-ID
Development of RApid Point of Care test Platforms for Infect...
16M€
Cerrado
EChiLiBRiST
Development and validation of a quantitative point of care t...
7M€
Cerrado
Información proyecto ZOONOMARKS
Duración del proyecto: 6 meses
Fecha Inicio: 2015-04-27
Fecha Fin: 2015-10-31
Líder del proyecto
OY REAGENA LTD
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
71K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Our major goal is development of simple to use point of care tests for zoonotic pathogens and viral hemorrhagic fevers (VHF), and their validation for use in clinical research setting.
Zoonosis is any process whereby an infectious disease is transmitted between different species of animals. The term zoonosis is here used specifically to refer to diseases that originate in other species of animal, but that get transmitted to humans. Zoonoses in which humans are infected may originate in either domestic animals or wildlife, such as insects, mammals, reptiles, bats, or birds.
This application contains a draft business plan with feasibility study that verifies the technical and economic viability of the new diagnostics in the proposed clinical validation.
In phase 1 a comprehensive business plan will be produced aiming in phase 2 to develop a comprehensive rapid response diagnostic system for zoonotic pathogens and hemorrhagic fever viruses, with implications for surveillance of all emerging pathogens. Furthermore, in phase 2 the developed tests will be evaluated by end users of the tests – by several research and clinical diagnostic laboratories.